This inventor holds 1 USPTO granted patent. Top assignee: Heumann Pharma Gmbh & Co.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Vergin Hartmut
Introduction
Vergin Hartmut is a notable inventor based in Nurnberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new salts for medicinal use. His work focuses on addressing inflammatory and rheumatic conditions, showcasing his commitment to improving healthcare.
Latest Patents
Hartmut holds a patent for "Salts of 2-(2,6-dichloroanilino)-phenylacetic acid." This patent describes a process for preparing new salts corresponding to a specific general formula. The salts, which include rubidium or caesium atoms, are designed for use in pharmaceutical preparations. These innovations can effectively treat various inflammatory and painful conditions, highlighting their potential impact on patient care.
Career Highlights
Throughout his career, Hartmut has been associated with Heumann Pharma GmbH & Co., where he has contributed to the development of pharmaceutical products. His expertise in the field has led to advancements that benefit both the industry and patients alike.
Collaborations
Hartmut has worked alongside notable colleagues such as Grafe Ingomar and Schickaneder Helmut. Their collaborative efforts have further enhanced the research and development of innovative pharmaceutical solutions.
Conclusion
Vergin Hartmut's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his dedication to advancing medical science. His work continues to have a positive impact on the treatment of inflammatory and rheumatic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile